COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Key Figures 31.01.2024
HBM Healthcare Investments AG released its key figures for January 31, 2024, with the net asset value (NAV) showing a performance of -7.0% for the month and 2.0% year-to-date. The share price experienced a decrease of 0.2% in the month and 11.4% year-to-date -
COMMUNIQUÉ RÉGLEMENTÉ
NRJ GROUP - Press release - 2023 revenue
NRJ Group reports continued strong growth in consolidated revenue for the 4th quarter of 2023, with radio and broadcasting activities leading the way, despite a slight drop in television revenue. The impressive audience share and commercial performance of NRJ's radio stations also contributed to this solid performance -
COMMUNIQUÉ RÉGLEMENTÉ
NRJ GROUP - Avis financier - Chiffre d'affaires 2023
NRJ Group enregistre une croissance soutenue du chiffre d'affaires consolidé au 4e trimestre 2023, avec une hausse de +5,1%, notamment grâce aux performances exceptionnelles de ses radios et à une progression de l'offre commerciale radio -
-
COMMUNIQUÉ DE PRESSE
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG releases notification of major holdings by The Goldman Sachs Group, Inc. with a change in breakdown of voting rights on subsidiary level -
-
COMMUNIQUÉ RÉGLEMENTÉ
Crit confirme son intention d’acquérir OpenjobMetis à l’issue des « Due Diligences »
Groupe Crit confirme son intention d’acquérir OpenjobMetis à l’issue des « Due Diligences ». L'acquisition serait subordonnée à la finalisation des accords de cession et à la levée de la condition suspensive relative aux autorisations administratives (anti-trust & Golden Power). Prochain rendez-vous : Résultats annuels 2023 : 19 mars 2024 après Bourse -
COMMUNIQUÉ DE PRESSE
Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists to Gather for the 2024 Tandem Meetings
The 2024 Tandem Meetings will unite international hematopoietic cell transplantation and cellular therapy specialists to discuss advancements and share insights in healthcare. The event will feature plenary and concurrent sessions, late-breaking abstracts, a poster hall, and an exhibit hall -
